Home > PJ > The Society / Daily News

Return to PJ Online Home Page

The Pharmaceutical Journal Vol 266 No 7149 p712
May 26, 2001


The Society

160th Annual General Meeting (May 16 2001)

2000 “a year of modernisation”

Presenting the annual review of the Council for 2000, the President, Christine Glover, told the annual general meeting that if there was a theme for the year it was “modernisation”. The plans to modernise the National Health Service formed a blueprint for the next 10 years of the delivery of health care. As part of that process, the roles of pharmacists were set to develop delivery of new approaches to the management of medicines that truly met the needs of patients.

Different solutions to health needs might well emerge in England, Scotland and Wales, but the health strategies for pharmacy published in all three countries positively reflected the themes been identified in the Society's strategy, “Building the future”. This strategy had provided the basis for dialogue with government, with health care professions, with politicians and with a whole gamut of opinion formers.

In England, pharmacy had been the first profession to have its own plan, with the launch of “Pharmacy in the future” in September, 2000. That plan's match with the Society's own strategy was stunning, but that was no coincidence because Council, staff and members had worked to achieve it.

In the three home countries, different approaches would share the common aim of modernising and improving pharmacy services. “Pharmacy in the future” had set out a wide-ranging programme to develop the NHS roles of the 30,000 pharmacists in England. The publication in December, 2000, of the Scottish Health Minister's plan for the NHS in Scotland had been a milestone pointing to better use of Scotland's 4,000 pharmacists. The launch in January, 2001, of the National Assembly for Wales health improvement strategy provided opportunities for Wales's 2,200 pharmacists to contribute to patient-focused health care.

The Society's modernisation process was designed to prepare pharmacists for future roles. The Society continued to address regulatory reform for the profession in the light of the powers found in the Health Act 1999 that enabled sweeping changes to be made to its existing regulatory structure.

Broad range of activities

The President went on to summarise the broad range of Society activities during 2000, as described in the annual review. Among other things, she referred to the Council's decision in the autumn of 2000 to suspend publication of the Industrial Pharmacist, the Agricultural and Veterinary Pharmacist, the Pharmacy Assistant and The Journal's British Pharmaceutical Conference pharmacy practice research supplement, because none was expected to secure enough advertising in 2001 to cover production costs. She added: “We have now found ways of continuing their publication at little or no cost to the Society.”

Concluding, the President said that the annual review was a celebration of success — but success came at a price. Raising the profession's profile and ensuring the Society had input in the places where it needed to have a voice, as well as working for the profession, was bound to put pressure on financial resources. To meet the challenges of the future, the Society had had to make some hard choices about priorities. Membership fees met the cost of the regulatory functions and went some way to fund the Society's role in professional leadership, but the Society had come to rely increasingly on the success of its publications business to help it to continue to do the things it needed to do to deliver change.

In the forthcoming year, those priorities had to be focused on the Society's role in implementing of the NHS plans in England, Scotland and Wales and on the underpinning proposals for reform of our disciplinary machinery. There was much to do if the Society was to maintain the momentum and the position it had established. That would require the active participation and support of the membership.

The President then said that the annual review for 2000 was open for questions and comments.

Asked to elaborate on her comments about the suspension of various publications, the President said that the things she had listed were all specialist magazines for particular interest groups. “When we were going through the budget to see where we could trim and what we ought to get rid off because it was costing us money, those happened to be all things that were costing us money instead of making us money, although I would have to say that when they were first proposed they were put to Council on the understanding that they would break even or indeed make us money but the reality is when this decision was made they were all losing us money, but they are only specialist magazines. The 50 per cent of our income comes from the great bulk of our publications — the BNF, Martindale, the specialist books, The Pharmaceutical Journal. What we would have to say is that the special interest groups were, not surprisingly, very put out at having their specialist magazines lost on the way so we scouted about, they have scouted about, and we have managed to get support so that they are no longer a loss on the sheet.”

Dr ANGELA ALEXANDER (Maidenhead) pointed out that the practice research supplement was not a specialist publication. She asked whether it would continue to be circulated to all pharmacists.

The SECRETARY AND REGISTRAR (Ann Lewis) said that it would be available on the website rather than circulated. There would be a review of the practice research in The Journal and the abstracts would be published as a supplement to the International Journal of Pharmacy Practice.

Dr ALEXANDER pointed out that it would therefore not go to all pharmacists.

The PRESIDENT said that it was about cost containment, but Dr Alexander had made the point well. “I think we have to put it on the website and see how it pans out. If it doesn't work we'll have to review it.”

The PRESIDENT then moved the adoption of the report, which was agreed.

Later, drawing the meeting to a close, the President said that it had been a great privilege to have been President for the past two years. She could not have done it without the support of the staff here at Lambeth, at Cardiff and in Edinburgh. They had been absolutely tremendous and she expressed her personal thanks to them all.

Retirement of Bill Darling

She also could not close without saying a proper thank you to Bill Darling, who was retiring from the Council. She had said in a special Council meeting that afternoon that Mr Darling's contribution to the profession has been exceptional and his honours and awards reflected the high regard in he was held, in and out of the profession. He had been made OBE and then CBE, he was a fellow and gold medallist of the Society, he was an honorary fellow of Sunderland University and he was now a deputy lieutenant for the County of Tyne and Wear. He had held a wide range of offices, was currently chairman of Gateshead and South Tyneside Health Authority, and still listed 12 other posts to his name.

Without doubt his breadth of knowledge of health matters had made a huge impact on the Council's thinking and decision-making and his wise counsel would be sorely missed. A particular personal contribution had been the development of three codes of ethics and the final one adopted by this AGM would be a lasting tribute.

The President added that she could not imagine Lambeth without Bill Darling. He had been a personal friend and a great support to her and she was sure that the meeting would want to wish him and his wife Ann very good health and a very successful life ahead without Lambeth.

Back to Top



©The Pharmaceutical Journal